Investigating chimeric RNAs in bladder cancer metastasis
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer
This study is looking at how certain RNA changes in bladder cancer might help the cancer spread through the lymph nodes, with the hope of finding new ways to diagnose and treat patients facing this tough disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10769861 on NIH RePORTER |
What this research studies
This research focuses on understanding how chimeric RNAs contribute to the spread of bladder cancer through lymphatic pathways. By studying gene fusions and RNA splicing processes, the researchers aim to identify unique chimeric RNAs that may serve as biomarkers or therapeutic targets. The approach involves advanced genomic techniques to analyze RNA samples from bladder cancer patients, particularly those with lymph node metastasis. This could lead to new diagnostic tools and treatment strategies for patients suffering from this aggressive form of cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with bladder cancer, especially those experiencing lymphatic metastasis.
Not a fit: Patients with non-metastatic bladder cancer or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and targeted therapies for bladder cancer patients, potentially enhancing survival rates.
How similar studies have performed: Previous research has shown promise in identifying gene fusions in other cancers, suggesting that this approach may yield valuable insights for bladder cancer as well.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Li, Hui — University of Virginia
- Study coordinator: Li, Hui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.